ArticleDiabetology & metabolic syndrome2025
A causal relationship between type 1 diabetes and risk of systemic sclerosis: a bidirectional two-sample Mendelian randomization study.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Causal Effects Between Antibody-Mediated Immune Responses and Parkinson's Disease: Insights from Genetic Studies.Cureus · 2026Article
- Causal Risk Factors for Type 1 Diabetes in Mendelian Randomization Studies: A Systematic Review and Meta-Analysis.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPrevious epidemiological observational studies have indicated an association between type 1 diabetes (T1DM) and systemic sclerosis (SSc). However, the potential causal relationship between T1DM and SSc remains unclear. Therefore, this Mendelian randomization (MR) study aims to investigate the bidirectional causal relationship between T1DM and SSc through a bidirectional two-sample mendelian randomization analysis.
methodsWe utilized SNP data aggregated from previously published genome-wide association studies (GWAS) and selected appropriate SNPs as instrumental variables (IVs). To explore the bidirectional causal relationship between T1DM and SSc, we conducted bidirectional Mendelian randomization analyses using various methods, including inverse variance weighted (IVW), MR-Egger, weighted median, and weighted mode approaches. Additionally, sensitivity analyses were performed to further validate the accuracy of the MR results.
resultsOur MR analysis using 66 SNPs as IVs for T1DM showed a genetically determined association with an increased risk of SSc (IVW OR = 1.294, 95% CI 1.140-1.469, p < 0.001), consistent across MR-Egger, weighted median, and weighted mode methods, with no evidence of horizontal pleiotropy or heterogeneity, and robustness confirmed by leave-one-out analysis. Conversely, reverse MR analysis using 7 SNPs for SSc revealed no significant association with T1DM (IVW OR = 0.998, 95% CI 0.979-1.016, P = 0.798), consistent across all methods, with no evidence of pleiotropy or heterogeneity, and results confirmed as robust.
conclusionThis pioneering mendelian randomization study reveals a causal link between genetic susceptibility to T1DM and an increased risk of SSc, though not vice versa, emphasizing the need for validation across diverse populations and further exploration of underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.